 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
4 News |  |
- | alpha-1-antitrypsin inhalation (VR179) / Vectura, Grifols
Enrollment change: Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis (clinicaltrials.gov) - Feb 8, 2016
P2, N=30, Completed, Sponsor: Grifols Therapeutics Inc.
N=41 --> 30
- | alpha-1-antitrypsin inhalation (VR179) / Vectura, Grifols
Enrollment change: Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis (clinicaltrials.gov) - Nov 25, 2013
P2, N=41, Completed, Sponsor: Grifols Therapeutics Inc.
N=41 --> 30 N=30 --> 41
- | alpha-1-antitrypsin inhalation (VR179) / Vectura, Grifols
Trial completion: Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis (clinicaltrials.gov) - Nov 25, 2013
P2, N=41, Completed, Sponsor: Grifols Therapeutics Inc.
N=30 --> 41 Active, not recruiting --> Completed
- | alpha-1-antitrypsin inhalation (VR179) / Vectura, Grifols
New P2 trial: Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis (clinicaltrials.gov) - Sep 11, 2012
P2, N=41, Completed, Sponsor: Grifols Therapeutics Inc.